FGF23 and chronic kidney disease: The CKD-MBD, characterized by the triad of hyperphosphatemia, high FGF23 levels and αKlotho deficiency is central to the pathophysiology of CKD-related cardiomyopathy, so that it can be considered part of the CKD-MBD puzzle.